| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |